396 related articles for article (PubMed ID: 34508608)
21. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status.
Xu S; Murtagh S; Han Y; Wan F; Toriola AT
JAMA Netw Open; 2024 Jan; 7(1):e2353331. PubMed ID: 38277147
[TBL] [Abstract][Full Text] [Related]
22. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
Eaglehouse YL; Georg MW; Shriver CD; Zhu K
JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
[TBL] [Abstract][Full Text] [Related]
23. Racial and Ethnic Disparities in Breast Cancer Survival: Emergence of a Clinically Distinct Hispanic Black Population.
Goel N; Yadegarynia S; Lubarsky M; Choi S; Kelly K; Balise R; Kesmodel SB; Kobetz E
Ann Surg; 2021 Sep; 274(3):e269-e275. PubMed ID: 34132699
[TBL] [Abstract][Full Text] [Related]
24. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
25. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
[TBL] [Abstract][Full Text] [Related]
26. Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer.
Liu P; Li X; Mittendorf EA; Li J; Du XL; He J; Ren Y; Yang J; Hunt KK; Yi M
Br J Cancer; 2013 Sep; 109(5):1302-9. PubMed ID: 23907433
[TBL] [Abstract][Full Text] [Related]
27. Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapy.
Wu X; Richardson LC; Kahn AR; Fulton JP; Cress RD; Shen T; Wolf HJ; Bolick-Aldrich S; Chen VW
J Natl Med Assoc; 2008 May; 100(5):490-8. PubMed ID: 18507201
[TBL] [Abstract][Full Text] [Related]
28. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
[TBL] [Abstract][Full Text] [Related]
29. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
Int J Epidemiol; 2019 Dec; 48(6):1897-1905. PubMed ID: 31155644
[TBL] [Abstract][Full Text] [Related]
30. Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate.
Krieger N; Chen JT; Waterman PD
Cancer Causes Control; 2011 Mar; 22(3):511-4. PubMed ID: 21188492
[TBL] [Abstract][Full Text] [Related]
31. Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics.
Ren JX; Gong Y; Ling H; Hu X; Shao ZM
Breast Cancer Res Treat; 2019 Jan; 173(1):225-237. PubMed ID: 30293212
[TBL] [Abstract][Full Text] [Related]
32. Updated racial disparities in incidence, clinicopathological features and prognosis of hypopharyngeal squamous carcinoma in the United States.
Liang Z; Wu M; Wang P; Quan H; Zhao J
PLoS One; 2023; 18(3):e0282603. PubMed ID: 36928727
[TBL] [Abstract][Full Text] [Related]
33. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
34. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
DeSantis CE; Fedewa SA; Goding Sauer A; Kramer JL; Smith RA; Jemal A
CA Cancer J Clin; 2016; 66(1):31-42. PubMed ID: 26513636
[TBL] [Abstract][Full Text] [Related]
36. Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status.
Cunningham JE; Montero AJ; Garrett-Mayer E; Berkel HJ; Ely B
Cancer Causes Control; 2010 Mar; 21(3):399-409. PubMed ID: 20024610
[TBL] [Abstract][Full Text] [Related]
37. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
[TBL] [Abstract][Full Text] [Related]
38. Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.
Brown D; Shao S; Jatoi I; Shriver CD; Zhu K
Cancer Epidemiol; 2016 Jun; 42():24-31. PubMed ID: 26999400
[TBL] [Abstract][Full Text] [Related]
39. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
40. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
